IRIDEX CORP Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
IRIDEX CORP (IRIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.30% for the 12-month period ending 2024-12-28, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-03-27
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -0.30%.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -0.30%.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.40%.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -17.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-28 | -0.30% 10-K · filed 2025-03-27 | |
| 2023-12-30 | -0.30% 10-K · filed 2025-03-27 | |
| 2022-12-31 | -0.40% 10-K · filed 2024-03-29 | 2.10% 10-K · filed 2023-03-09 |
| 2022-01-01 | -17.10% 10-K · filed 2023-03-09 | 17.10% 10-K · filed 2022-03-15 |
| 2021-01-02 | -2.80% 10-K · filed 2022-03-15 | |
| 2019-12-28 | -3.40% 10-K · filed 2021-03-23 | |
| 2018-12-29 | -0.40% 10-K · filed 2020-03-13 | |
| 2017-12-30 | 0.00% 10-K · filed 2019-03-29 | |
| 2016-12-31 | -1.50% 10-K · filed 2018-03-14 | |
| 2016-01-02 | 12.00% 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |